When starting a GLP-1 medication, most people are focused on weight loss and blood sugar control. But a few months in, many find themselves asking a different question: what is happening to my sex drive?
It is a question worth taking seriously. Sexual health is a core part of overall wellbeing — and the relationship between GLP-1 treatment, body weight, and libido is more nuanced than a simple yes or no.
Does GLP-1 medication reduce libido?
Not directly. GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) do not act on sexual hormone pathways. However, the early weeks of treatment frequently bring nausea, fatigue, and a general reduction in the pleasure associated with eating — and when you feel unwell and exhausted, desire naturally takes a back seat.
For most people, these side effects are temporary. As the body adapts to the medication — typically within the first 8–12 weeks — they tend to diminish considerably. Many users report that their libido returns to baseline or even improves once the adjustment phase has passed.
Weight loss improves sexual function — especially in men
The more significant story plays out over the longer term. A growing body of clinical research shows that weight loss — including weight loss achieved with GLP-1 medications — is associated with meaningful improvements in sexual function.
For men with obesity, the mechanism is well understood. Fat tissue, especially visceral (abdominal) fat, contains an enzyme called aromatase that converts testosterone into estrogen. The more fat tissue a man carries, the more testosterone is converted — resulting in lower circulating testosterone, reduced libido, and in some cases erectile dysfunction. A large cohort study published in the Journal of Clinical Endocrinology & Metabolism (PMC7983380) confirms that obesity is strongly associated with low testosterone, and that weight loss reverses this relationship.
A 2024 clinical study (PubMed: 38503485) specifically examining semaglutide found significant improvements in testosterone levels in men with obesity and type 2 diabetes after 12 months of treatment. A further study (PubMed: 37271708) showed that a weight loss of 10–15% of body weight was associated with clinically meaningful improvements in sexual function scores in men with obesity.
What about women?
The picture for women is more nuanced. Hormonal balance is undeniably influenced by body weight in women: excess weight can disrupt the menstrual cycle, alter estrogen and androgen levels, and contribute to conditions such as polycystic ovary syndrome (PCOS), all of which are associated with reduced libido and sexual wellbeing.
Weight loss in women with obesity has been shown to improve hormonal balance, reduce PCOS symptoms, and in many cases improve sexual satisfaction. However, direct clinical evidence specifically linking GLP-1 medication to improved libido in women is still limited. The systematic review in PMC10556730 focused primarily on male sexual function, and further research in women is needed.
What is clearly relevant for all genders: improved body image after weight loss is one of the most consistently reported factors associated with better sexual wellbeing.
Body image and self-confidence matter
Psychological factors play an enormous role in sexual desire. Many people who have lived with obesity for years describe feeling disconnected from their bodies or uncomfortable with physical intimacy. As weight loss progresses, many users report a renewed sense of confidence — feeling more at ease in their own skin and more willing to be present in intimate situations.
This is not a minor effect. Qualitative research consistently shows that self-perception and body confidence are among the most important drivers of libido, often outweighing purely hormonal factors. The psychological uplift of meaningful weight loss can be just as powerful as any hormonal shift.
What does clinical research show?
A systematic review published in PMC10556730 examined the relationship between GLP-1 receptor agonists and sexual function. The review found that GLP-1 treatment was associated with improvements in sexual function scores in men, largely mediated by weight loss and improved testosterone levels. Direct receptor-level effects on sexual function could not be excluded, but weight loss remained the primary driver of benefit.
This is genuinely encouraging news for the many people using these medications: beyond weight loss and metabolic improvement, sexual wellbeing may improve as well.
Practical tips to support your sexual health
1. Give it time
Early side effects — nausea, fatigue, reduced appetite — are real, but typically temporary. Most users find these subside significantly by weeks 8–12. If your libido has dipped early in treatment, it may simply be your body adjusting. Hold on before drawing conclusions.
2. Prioritise protein intake
GLP-1 medications significantly reduce appetite, which can lead to inadequate protein intake. Protein is essential for testosterone production and overall hormonal health. Aim for at least 1.2–1.6 grams per kilogram of body weight per day, distributed across meals. Prioritise eggs, fish, chicken, legumes, and dairy.
3. Exercise regularly
Physical activity — especially resistance training — supports testosterone levels, improves mood, increases energy, and directly benefits sexual function. Even 2–3 sessions per week of strength training make a measurable difference. Consistency matters more than intensity.
4. Communicate with your partner
Changes in libido during a significant health transition are normal and worth talking about. Open communication with a partner reduces pressure, builds understanding, and often resolves concerns that could otherwise become sources of tension.
5. Talk to your doctor
If libido issues persist beyond the initial adjustment period, or if you are experiencing other symptoms such as persistent fatigue, low mood, or signs of hormonal imbalance, speak to your doctor. Hormonal testing — including testosterone — can reveal whether specific treatment is warranted.
Conclusion
GLP-1 medications do not directly suppress libido. Some users experience a temporary reduction early in treatment as a consequence of side effects — but for most, especially men with obesity, the trajectory is positive. As weight is lost, testosterone levels improve, body image improves, and sexual function often follows. The research supports what many users already experience firsthand.
As always, if you have concerns about your sexual health during treatment, speak to your doctor. Your experience matters, and there are good tools available to help.
Medical disclaimer
The information in this article is for general educational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that must be used under medical supervision. Always consult a qualified healthcare professional with any concerns about your treatment or your sexual health.